Who owns PYXIS ONCOLOGY INC?
- Ticker: PYXS
- CUSIP Number: 747324101
Tip: Access positions for across all investors
Analyze quarterly positions in Pyxis Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Pyxis Oncology stock
Who bought or sold PYXIS ONCOLOGY INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Laurion Capital Management | 3.9M | $16M | 22% | Mar 2024 |
|
Balyasny Asset Management | 2.6M | $11M | 100% | Mar 2024 |
|
Ikarian Capital | 1.7M | $7.1M | 100% | Mar 2024 |
|
Vanguard Group | 1.4M | $6.0M | 7% | Mar 2024 |
|
Standard Life Aberdeen | 708k | $3.0M | 0% | Mar 2024 |
|
Millennium Management | 657k | $2.8M | 4853% | Mar 2024 |
|
Superstring Capital Management | 494k | $2.1M | 100% | Mar 2024 |
|
Boothbay Fund Management | 493k | $2.1M | 100% | Mar 2024 |
|
Monashee Investment Management | 443k | $1.9M | 100% | Mar 2024 |
|
Hillhouse Capital Advisors | 383k | $689k | 0% | Dec 2023 |
|
Geode Capital Management | 340k | $1.4M | 18% | Mar 2024 |
|
Goldman Sachs Group | 337k | $1.4M | 100% | Mar 2024 |
|
Decheng Capital | 327k | $588k | 100% | Dec 2023 |
|
BlackRock | 322k | $1.4M | 7% | Mar 2024 |
|
Bridgeway Capital Management | 232k | $986k | -2% | Mar 2024 |
|
Jane Street | 175k | $747k | 1067% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 165k | $703k | 32% | Mar 2024 |
|
Bank of New York Mellon | 162k | $691k | 905% | Mar 2024 |
|
Qube Research & Technologies | 153k | $652k | 7650200% | Mar 2024 |
|
Man Group | 147k | $627k | 100% | Mar 2024 |
|
Hrt Financial | 139k | $592k | 100% | Mar 2024 |
|
Marshall Wace | 134k | $569k | 100% | Mar 2024 |
|
Susquehanna International | 104k | $445k | 86% | Mar 2024 |
|
Dimensional Fund Advisors | 102k | $434k | 0% | Mar 2024 |
|
ExodusPoint Capital Management | 90k | $381k | -78% | Mar 2024 |
|
Susquehanna Fundamental Investments | 82k | $351k | 100% | Mar 2024 |
|
CornerCap Investment Counsel | 75k | $319k | 0% | Mar 2024 |
|
Squarepoint Ops | 68k | $291k | 100% | Mar 2024 |
|
XTX Topco | 66k | $281k | 100% | Mar 2024 |
|
Cable Car Capital | 62k | $262k | 0% | Mar 2024 |
|
Northern Trust | 61k | $261k | 16% | Mar 2024 |
|
Marathon Trading Investment Management | 57k | $243k | 100% | Mar 2024 |
|
Pier 88 Investment Partners | 51k | $219k | 100% | Mar 2024 |
|
University Of Chicago | 49k | $208k | 0% | Mar 2024 |
|
Citigroup | 45k | $190k | 100% | Mar 2024 |
|
Morgan Stanley | 44k | $185k | 1260% | Mar 2024 |
|
American Century Companies | 37k | $159k | 171% | Mar 2024 |
|
Brevan Howard Capital Management | 36k | $153k | 100% | Mar 2024 |
|
Citadel Advisors | 30k | $130k | -72% | Mar 2024 |
|
Commonwealth Equity Services | 30k | $129k | 134% | Mar 2024 |
|
Point72 Asia | 30k | $127k | 100% | Mar 2024 |
|
Bank of America Corporation | 30k | $127k | 50% | Mar 2024 |
|
UBS Group | 28k | $120k | 856% | Mar 2024 |
|
Y-Intercept | 28k | $120k | 100% | Mar 2024 |
|
Royal Bank of Canada | 26k | $109k | 2586% | Mar 2024 |
|
Schulhoff & Company | 22k | $94k | 0% | Mar 2024 |
|
NEOS Investment Management | 16k | $69k | 100% | Mar 2024 |
|
Two Sigma Advisers | 16k | $67k | -76% | Mar 2024 |
|
Charles Schwab Investment Management | 15k | $62k | 100% | Mar 2024 |
|
SG Americas Securities | 14k | $59k | 100% | Mar 2024 |
|
Sawtooth Asset Management | 11k | $20k | 0% | Dec 2023 |
|
William Blair $ Company | 10k | $43k | 100% | Mar 2024 |
|
ADAR1 Capital Management | 10k | $43k | 100% | Mar 2024 |
|
Tower Research Capital | 9.7k | $41k | 389% | Mar 2024 |
|
Advisor Group Holdings | 3.1k | $13k | 18% | Mar 2024 |
|
Wells Fargo & Company | 834.00 | $3.6k | -67% | Mar 2024 |
|
Jpmorgan Chase & Co | 500.00 | $2.1k | 0% | Mar 2024 |
|
Goss Wealth Management | 250.00 | $1.1k | -86% | Mar 2024 |
|
Hanson McClain Advisors | 200.00 | $852.000000 | 0% | Mar 2024 |
|
Coston, McIsaac & Partners | 30.00 | $0 | 0% | Mar 2024 |
|
West Branch Capital | 25.00 | $107.000000 | 0% | Mar 2024 |
|
FMR | 1.00 | $4.000000 | -100% | Mar 2024 |
|
Who sold out of Pyxis Oncology?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Harvest Investment Services | Dec 2023 | 112k | $202k |
Two Sigma Investments | Dec 2023 | 92k | $165k |
Acadian Asset Management | Sep 2023 | 13k | $26k |
Bleakley Financial Group | Dec 2023 | 11k | $20k |
Kingsview Wealth Management | Dec 2023 | 11k | $19k |
Springbok Capital Management | Sep 2023 | 10k | $21k |
Group One Trading | Sep 2023 | 3.1k | $6.1k |
Gradient Investments | Dec 2023 | 1.00 | $2.000000 |